Joseph Pawluczyk

691 total citations
21 papers, 490 citations indexed

About

Joseph Pawluczyk is a scholar working on Organic Chemistry, Molecular Biology and Social Psychology. According to data from OpenAlex, Joseph Pawluczyk has authored 21 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 9 papers in Molecular Biology and 8 papers in Social Psychology. Recurrent topics in Joseph Pawluczyk's work include Neuroendocrine regulation and behavior (8 papers), Organic and Inorganic Chemical Reactions (6 papers) and Chemical Synthesis and Analysis (5 papers). Joseph Pawluczyk is often cited by papers focused on Neuroendocrine regulation and behavior (8 papers), Organic and Inorganic Chemical Reactions (6 papers) and Chemical Synthesis and Analysis (5 papers). Joseph Pawluczyk collaborates with scholars based in United States, India and Germany. Joseph Pawluczyk's co-authors include James Kempson, Roger Freidinger, T. G. Murali Dhar, Arvind Mathur, Nicholas A. Meanwell, Martins S. Oderinde, Antonio Ramı́rez, Lyndon A. M. Cornelius, Christine Jorge and Douglas J. Pettibone and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Joseph Pawluczyk

20 papers receiving 475 citations

Peers

Countries citing papers authored by Joseph Pawluczyk

Since Specialization

Citations

This map shows the geographic impact of Joseph Pawluczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Pawluczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Pawluczyk more than expected).

Fields of papers citing papers by Joseph Pawluczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Pawluczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Pawluczyk. The network helps show where Joseph Pawluczyk may publish in the future.

Co-authorship network of co-authors of Joseph Pawluczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Pawluczyk. A scholar is included among the top collaborators of Joseph Pawluczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Pawluczyk. Joseph Pawluczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Process Development of a Macrocyclic Peptide Inhibitor of PD-L1 2024 ·The Journal of Organic Chemistry ·Subha Mukherjee, (unknown), Gardner S. Creech, Chao Hang, Antonio Ramı́rez, (unknown), (unknown), Claudio Mapelli, Serge Zaretsky, (unknown), (unknown), (unknown), (unknown), James Kempson, Joseph Pawluczyk, Martin P. Allen, Rodney L. Parsons, Chris Sfouggatakis	4
2	Development of a Rapid Scale-Up Synthesis of (S)-N-(8-((2-Amino-2,4-dimethylpentyl)oxy)-5H-chromeno[3,4-c]pyridin-2-yl)acetamide, a Potent Adaptor-Associated Kinase 1 Inhibitor 2022 ·Organic Process Research & Development ·Jianqing Li, Daniel Smith, Joseph Pawluczyk, Subramaniam Krishnananthan, Bei Wang, (unknown), (unknown), James Kempson, Dawn Sun, Shiuhang Yip, Dauh‐Rurng Wu, (unknown), Muthalagu Vetrichelvan, Anuradha Gupta, John E. Macor, Carolyn D. Dzierba, Arvind Mathur	4
3	Synthesis of Cyclobutane-Fused Tetracyclic Scaffolds via Visible-Light Photocatalysis for Building Molecular Complexity 2020 ·Journal of the American Chemical Society ·Martins S. Oderinde, Edna Mao, Antonio Ramı́rez, Joseph Pawluczyk, Christine Jorge, Lyndon A. M. Cornelius, James Kempson, Muthalagu Vetrichelvan, (unknown), Anuradha Gupta, Arun Kumar Gupta, Nicholas A. Meanwell, Arvind Mathur, T. G. Murali Dhar	118
4	Photocatalytic Dearomative Intermolecular [2 + 2] Cycloaddition of Heterocycles for Building Molecular Complexity 2020 ·The Journal of Organic Chemistry ·Martins S. Oderinde, Antonio Ramı́rez, T. G. Murali Dhar, Lyndon A. M. Cornelius, Christine Jorge, Darpandeep Aulakh, Bhupinder Sandhu, Joseph Pawluczyk, Amy A. Sarjeant, Nicholas A. Meanwell, Arvind Mathur, James Kempson	64
5	Route evaluation and development of a practical synthesis of methyl (S)-2-chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-7-carboxylate 2020 ·Tetrahedron ·Joseph Pawluczyk, James Kempson, Arvind Mathur, Martins S. Oderinde	0
6	A mild and readily scalable procedure for the N-1-difluoromethylation of ethyl 6-((tert-butyldiphenylsilyl)oxy)-1H-indazole-3-carboxylate and its applications to the N-difluoromethylation of indazole, benzotriazole, imidazole, indole and pyrazole derivatives 2020 ·Journal of Fluorine Chemistry ·(unknown), (unknown), (unknown), Jianqing Li, Joseph Pawluczyk, Bei Wang, James Kempson, Purnima Khandelwal, Leon M. Smith, Peter W. Glunz, (unknown)	4
7	Synthesis of 1-(tert-Butyl) 4-Methyl (1R,2S,4R)-2-Methylcyclohexane-1,4-dicarboxylate from Hagemann’s tert-Butyl Ester for an Improved Synthesis of BMS-986251 2020 ·The Journal of Organic Chemistry ·Lyndon A. M. Cornelius, Jianqing Li, Daniel Smith, Subramaniam Krishnananthan, Shiuhang Yip, Dauh‐Rurng Wu, Joseph Pawluczyk, Darpandeep Aulakh, Amy A. Sarjeant, James Kempson, Joseph A. Tino, Arvind Mathur, T. G. Murali Dhar, Robert J. Cherney	5
8	Intramolecular [2+2] Cycloaddition of N‐Allylcinnamamines and N‐Allylcinnamamides by Visible‐Light Photocatalysis 2019 ·European Journal of Organic Chemistry ·Martins S. Oderinde, James Kempson, Daniel Smith, Nicholas A. Meanwell, Edna Mao, Joseph Pawluczyk, Muthalagu Vetrichelvan, (unknown), (unknown), Richard Rampulla, Jianqing Li, T. G. Murali Dhar, Arvind Mathur	22
9	Microwave-initiated living free radical polymerization: optimization of the preparative scale synthesis of Rasta resins 2007 ·Tetrahedron Letters ·Joseph Pawluczyk, Ray T. McClain, (unknown), (unknown), Deanne Jackson Rudd, Craig W. Lindsley	19
10	Applications of Microwave‐Assisted Organic Synthesis on the Multigram Scale 2006 ·ChemInform ·S. E. Wolkenberg, William D. Shipe, Craig W. Lindsley, James P. Guare, Joseph Pawluczyk	4
11	Design and Synthesis of a Pro-Drug of Vinblastine Targeted at Treatment of Prostate Cancer with Enhanced Efficacy and Reduced Systemic Toxicity 2002 ·Journal of Medicinal Chemistry ·Stephen F. Brady, Joseph Pawluczyk, Patricia K. Lumma, Dong-Mei Feng, Jenny Wai, Raymond C. F. Jones, Deborah Defeo-Jones, Bradley K. Wong, Cynthia Miller‐Stein, Jiunn H. Lin, Allen Oliff, Roger Freidinger, Victor M. Garsky	43
12	A prostate-specific antigen (PSA)-activated vinblastine prodrug selectively kills PSA-secreting cells in vivo. 2002 ·PubMed ·Deborah Defeo-Jones, Stephen F. Brady, Dong-Mei Feng, (unknown), (unknown), Kathleen Haskell, DAVID M. KIEFER, Karen Leander, Elizabeth McAvoy, Patricia K. Lumma, Joseph Pawluczyk, Jenny Wai, Sherri L. Motzel, Kevin J Keenan, (unknown), Jiunn H. Lin, Victor M. Garsky, Roger Freidinger, Allen Oliff, Raymond E. Jones	33
13	Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency 1999 ·Bioorganic & Medicinal Chemistry Letters ·Peter D. Williams, Mark G. Bock, B. Evans, Roger Freidinger, Steven N. Gallicchio, (unknown), Marlene A. Jacobson, (unknown), (unknown), Edward V. Lis, Stuart R. Michelson, Joseph Pawluczyk, Debra S. Perlow, Douglas J. Pettibone, (unknown), Duane R. Reiss, Christopher Salvatore, Kenneth J. Stauffer, (unknown)	13
14	Nonpeptide oxytocin antagonists: Potent, orally bioavailable analogs of L-371,257 containing A 1-R-(pyridyl)ethyl ether terminus 1998 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Mark G. Bock, Roger Freidinger, (unknown), Edward V. Lis, Joseph Pawluczyk, Debra S. Perlow, Douglas J. Pettibone, (unknown), Duane R. Reiss, Peter D. Williams, (unknown)	9
15	Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines 1998 ·Journal of Medicinal Chemistry ·Ian M. Bell, Jill M. Erb, Roger Freidinger, Steven N. Gallicchio, James P. Guare, (unknown), Rita A. Halpin, Doug W. Hobbs, Carl F. Homnick, (unknown), Edward V. Lis, David J. Mathre, Stuart R. Michelson, Joseph Pawluczyk, Douglas J. Pettibone, Duane R. Reiss, S. Vickers, Peter D. Williams, (unknown)	47
16	ChemInform Abstract: 1‐(1‐(4‐((N‐Acetyl‐4‐piperidinyl)oxy)‐2‐methoxybenzoyl)piperidin‐4‐yl)‐ 4H‐3,1‐benzoxazin‐2(1H)‐one (L‐371,257): A New, Orally Bioavailable, Non‐Peptide Oxytocin Antagonist. 1996 ·ChemInform ·Paul Williams, Bradley V. Clineschmidt, Jill M. Erb, Roger Freidinger, (unknown), Edward V. Lis, Joseph Pawluczyk, D. J. PETTIBONE, Duane R. Reiss, Daniel F. Veber, (unknown)	7
17	1-[1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2- methoxybenzoyl]piperidin-4-yl]-4H-3,1- benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist. 1995 ·Journal of Medicinal Chemistry ·Paul Williams, Bradley V. Clineschmidt, Jill M. Erb, Roger Freidinger, (unknown), Edward V. Lis, Joseph Pawluczyk, Douglas J. Pettibone, Duane R. Reiss	51
18	Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformation. 1994 ·Bioorganic & Medicinal Chemistry ·Peter D. Williams, Richard G. Ball, Bradley V. Clineschmidt, J. Chris Culberson, Jill M. Erb, Roger Freidinger, Joseph Pawluczyk, Debra S. Perlow, Douglas J. Pettibone, Daniel F. Veber	4
19	ChemInform Abstract: 1‐(((7,7‐Dimethyl‐2(S)‐(2(S)‐amino‐4‐(methylsulfonyl)butyramido) bicyclo(2.2.1)heptan‐1(S)‐yl)methyl)sulfonyl)‐4‐(2‐methylphenyl) piperazine (L‐368,899): An Orally Bioavailable, Non‐Peptide Oxytocin Antagonist with Potential Utility for Managing Preterm Labor. 1994 ·ChemInform ·Paul Williams, Paul Anderson, Richard G. Ball, Mark G. Bock, (unknown), Simon Chiu, Bradley V. Clineschmidt, J. Chris Culberson, Jill M. Erb, B. Evans, Stephanie L. Fitzpatrick, Roger Freidinger, Marc J. Kaufman, G. F. Lundell, (unknown), Joseph Pawluczyk, Debra S. Perlow, Douglas J. Pettibone, Steven M. Pitzenberger	13
20	Nanomolar-affinity, non-peptide oxytocin receptor antagonists 1993 ·Journal of Medicinal Chemistry ·B. Evans, G. F. Lundell, Kevin F. Gilbert, Mark G. Bock, Kenneth E. Rittle, (unknown), Peter D. Williams, Joseph Pawluczyk, James L. Leighton	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact